One in Five Children Globally Has Excess Weight
By Lori Solomon HealthDay Reporter
TUESDAY, June 11, 2024 -- One in five children or adolescents globally experience excess weight, according to a study published online June 10 in JAMA Pediatrics.
Xinyue Zhang, Ph.D., from Sichuan University in Chengdu, China, and colleagues conducted a systematic literature review to estimate worldwide prevalence of overweight and obesity in children and adolescents from 2000 to 2023 and to assess potential risk factors for and comorbidities of obesity.
Based on 2,033 studies (154 different countries or regions; 45.9 million individuals), the researchers found that the overall prevalence of obesity in children and adolescents was 8.5 percent. Prevalence varied across countries, ranging from 0.4 percent (Vanuatu) to 28.4 percent (Puerto Rico). Countries with Human Development Index scores of ≥0.8 and high-income countries or regions had a higher prevalence of obesity among children and adolescents. There was a 1.5-fold increase in the prevalence of obesity in 2012 to 2023 compared with 2000 to 2011. A high risk for depression and hypertension was seen in children and adolescents with obesity. The pooled estimate of overweight was 14.8 percent and excess weight was 22.2 percent in children and adolescents.
"Excess weight among children and adolescents was associated with a mix of inherent, behavioral, environmental, and sociocultural influences that need the attention and committed intervention of primary care professionals, clinicians, health authorities, and the general public," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-06-12 07:15
Read more
- Overall Burden of CVD Remained High in United Kingdom in 2000 to 2019
- Past-Year Pap Testing Rates Were Lower in 2022 Than 2019
- Stem Cell Therapy Could Be Breakthrough Against Type 1 Diabetes
- Timing of Exercise Significant for Obesity, Metabolic Impairment
- FDA Approves Ohtuvayre (ensifentrine) for the Maintenance Treatment of Chronic Obstructive Pulmonary Disease (COPD)
- 1990 to 2019 Saw Increase in Life Expectancy in Seniors With T1DM
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- penginapan di alahan panjang
- nutrition faktory
- doksisiklin
- waist adalah
- kolonoskopi adalah
- obat glimepiride
- antiemetik adalah
- efek samping metformin
- sudut 45 derajat
- plasebo adalah
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions
- qulipta side effects anxiety
- repotrectinib side effects
- ibrance para que sirve
- foods to avoid while taking enbrel
- 反応 速度 鍛える
- baby shampoo eczema
- cdk inhibitor breast cancer
- xulane package insert
- loryna side effects
- keytruda pi
- estarylla vs sprintec
- pros and cons of junel birth control
- tissue plasminogen activator
- jolessa
- ワセリン ベビー パウダー
- tintes para piel morena
- parp 阻害 薬
- デスモイド
- erau ernie
- vasoplex side effects
- rutina de hombros
- merk pre workout
- 湾曲ペニス
- best work out shoes
- ウィニペグ大学
- transparent labs creatine hmb
- nutrition faktory
- メトホルミン 効果発現
- お 風呂 おもちゃ 赤ちゃん
- メトホルミン 副作用